These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11058880)

  • 1. Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.
    Wang DS; Rieger-Christ K; Latini JM; Moinzadeh A; Stoffel J; Pezza JA; Saini K; Libertino JA; Summerhayes IC
    Int J Cancer; 2000 Nov; 88(4):620-5. PubMed ID: 11058880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation of PTEN in bladder carcinoma.
    Aveyard JS; Skilleter A; Habuchi T; Knowles MA
    Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
    Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
    Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
    Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point mutations of the Mxil gene are rare in prostate cancers.
    Kawamata N; Park D; Wilczynski S; Yokota J; Koeffler HP
    Prostate; 1996 Sep; 29(3):191-3. PubMed ID: 8827088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines.
    Wang DY; Xiang YY; Li XJ; Hashimoto M; Tanaka M; Sugimura H
    Pathol Int; 2000 May; 50(5):373-83. PubMed ID: 10849326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.
    Simpkins SB; Peiffer-Schneider S; Mutch DG; Gersell D; Goodfellow PJ
    Gynecol Oncol; 1998 Dec; 71(3):391-5. PubMed ID: 9887237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo.
    Herbst RA; Podewski EK; Mommert S; Kapp A; Weiss J
    Arch Dermatol Res; 1999 Oct; 291(10):567-9. PubMed ID: 10552217
    [No Abstract]   [Full Text] [Related]  

  • 10. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
    Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
    Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.
    Prochownik EV; Eagle Grove L; Deubler D; Zhu XL; Stephenson RA; Rohr LR; Yin X; Brothman AR
    Genes Chromosomes Cancer; 1998 Aug; 22(4):295-304. PubMed ID: 9669667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
    Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
    Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.